Synthace Stock
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.
Sign up today and learn more about Synthace Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthace Stock
Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.
Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.
Funding History
| August 2013 | $1.5M |
|---|---|
| January 2015 | $2.9M |
| September 2017 | $10.5M |
| June 2018 | $3.1M |
| December 2018 | $25.4M |
| November 2021 | $6.8M |
| November 2021 | $26.8M |
Management
CEO
Guy Levy-Yurista
Co-founder & Chief Scientific Officer
Markus Gershater
Chief Product Officer
Mathieu Ayel
Press
businesswire - May, 24 2023
Synthace combines ChatGPT and digital experiments in first step toward a true AI scientistbusinesswire - Apr, 5 2023
Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yetpharmiweb - Sep, 7 2022
Synthace Appoints Dr. Donald Deieso as New Board Chairprnewswire - Dec, 7 2021
IDBS and Synthace announce strategic partnership to streamline bioprocess data managementtech - Nov, 17 2021
Synthace raises $35 million, helps scientists automate biology experimentation and insight sharingbusinesscloud - Nov, 17 2021
Synthace raises £26m to automate drug developmentfinsmes - Nov, 16 2021
Synthace Raises $35M in Series C Fundingow - May, 20 2021
Veteran Technology Executive Joins Synthace to Accelerate its Mission to Revolutionize the Life Science Research Marketzpr - Mar, 9 2021
Synthace Appoints Dr. Nick Jurascheck as VP of Engineeringuktech - Nov, 5 2020
Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automationsofinnovapartners - Jun, 11 2020
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automationforbes - Jul, 22 2019
Meet The Startup Revolutionizing The Language Of Biologybusinesswire - Oct, 1 2018
Synthace Launches Ground-Breaking New Whitepaper: Computer-Aided Biology: Delivering Biotechnology in the 21st Centurysynthace - Apr, 26 2018
Synthace Appoints Bob Wiederhold as Chairman of its Board of Directorsbusinesswire - Apr, 12 2018
Gilson and Synthace Announce Collaboration Aiming to Make Biological Research More Efficient and Reproducible at Analytica 2018news-medical - Apr, 10 2018
Collaboration between Gilson and Synthace revealed at Analytica 2018spectrum - May, 3 2017
Software Startups Aim to Automate Bio Labsbloomberg - Nov, 2 2016
The Internet of Very Expensive Thingsbusinesswire - Jun, 30 2016
Synthace Awarded Technology Pioneer by World Economic Forumprnewswire - Apr, 10 2016
Synthace Partners With Microsoft to Bring Antha to Azuretechcitynews - Jan, 15 2016
Where smart tech investment is going this yearprnewswire - Oct, 28 2015
Synthace Announces Collaboration with MSD to Develop Biomanufacturing Platformprnewswire - Oct, 28 2015
Synthace Announces Collaboration With Merck to Develop Biomanufacturing Platformfinsmes - Sep, 24 2013
FinSMEs | Synthace Raises 1.3MEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
